- Cooper University Health Care selects Corero Network Security's CORE Zero Trust Admission Control (ZTAC) for enhanced network security.
- This marks the first implementation of Corero's ZTAC solution in a healthcare setting.
- Cooper University Health Care operates with nearly 11,000 team members and leverages ZTAC to protect critical systems.
Corero Network Security (OTCQX: DDOSF) has announced that Cooper University Health Care, a leading academic health system in South Jersey, has chosen its CORE Zero Trust Admission Control (ZTAC) solution to enhance its network security systems. This deployment represents the first instance of Corero's ZTAC technology being used in the healthcare sector.
The CORE ZTAC solution will bolster Cooper's digital infrastructure by ensuring that only pre-authenticated users can access critical systems, offering real-time mitigation of attacks, and securing remote access infrastructure. These enhancements are vital in protecting against sophisticated threats that frequently target healthcare environments.
Cooper University Health Care encompasses a comprehensive health system with a team of nearly 11,000 members, including over 1,000 physicians and more than 1,600 nurses. The organization provides a wide range of services, including primary, specialty, tertiary, and urgent care, and consistently seeks innovative solutions to ensure the continuous availability of care-critical systems. By implementing Corero’s ZTAC, Cooper is committing to operational resilience and advanced cybersecurity measures.
Carl Herberger, CEO at Corero Network Security, expressed pride in partnering with Cooper University Health Care, acknowledging the increasing necessity of zero trust frameworks to ensure the integrity and security of healthcare digital infrastructures.
Corero Network Security is recognized for its expertise in DDoS protection solutions and offers automatic detection and protection services with extensive network visibility, analytics, and reporting tools. Corero is headquartered in London and operates across Marlborough, Massachusetts, USA, and Edinburgh, UK. The company's stocks are listed under the ticker symbol DDOSF on the US OTCQX Market and CNS on the London Stock Exchange's AIM market.
